Boron in medicinal and organic chemistry
dc.contributor.author | Prates, João Lucas Bruno [UNESP] | |
dc.contributor.author | Pavan, Aline Renata [UNESP] | |
dc.contributor.author | Dos Santos, Jean Leandro [UNESP] | |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | |
dc.date.accessioned | 2022-04-29T08:36:19Z | |
dc.date.available | 2022-04-29T08:36:19Z | |
dc.date.issued | 2021-08-01 | |
dc.description.abstract | Nowadays, boron-containing compounds have gained researchers’ attention because of the wide versatility and applicability of this element in both organic and medicinal chemistry. Since its discovery, its use in medicinal chemistry was neglected because of its possible toxic effects. However, in the past years, boron-containing compounds did not show such effects, and some drugs have already been approved by the Food and Drug Administration to treat diseases, including cancer, infections, and inflammation. Several boroncontaining compounds are used in organic and medicinal chemistry, either as a reagent or therapeutic agent. The chemical properties of this element make its use possible in organic synthesis as a reducing agent and catalyst, mainly in cross-coupling reactions. Among boroncontaining compounds, boranes, azaborines, benzoxaborole, boronic acid, and boron deriva tives are most commonly described. This review article discusses the main properties of boron-containing compounds, their preparation by organic synthesis, as well as their applications in organic synthesis and medicinal chemistry fields, developing new perspectives for further investigations. | en |
dc.description.affiliation | Department of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University (UNESP) | |
dc.description.affiliation | Institute of Chemistry São Paulo State University (UNESP) | |
dc.description.affiliationUnesp | Department of Drugs and Medicines School of Pharmaceutical Sciences São Paulo State University (UNESP) | |
dc.description.affiliationUnesp | Institute of Chemistry São Paulo State University (UNESP) | |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorshipId | CAPES: 001 | |
dc.description.sponsorshipId | FAPESP: 2018/11079-0 | |
dc.description.sponsorshipId | FAPESP: 2018/195237 | |
dc.description.sponsorshipId | CNPq: 304731/2017-0 | |
dc.format.extent | 1853-1867 | |
dc.identifier | http://dx.doi.org/10.2174/1385272825666210625120209 | |
dc.identifier.citation | Current Organic Chemistry, v. 25, n. 16, p. 1853-1867, 2021. | |
dc.identifier.doi | 10.2174/1385272825666210625120209 | |
dc.identifier.issn | 1385-2728 | |
dc.identifier.scopus | 2-s2.0-85118948071 | |
dc.identifier.uri | http://hdl.handle.net/11449/229871 | |
dc.language.iso | eng | |
dc.relation.ispartof | Current Organic Chemistry | |
dc.source | Scopus | |
dc.subject | Benzoxaborole | |
dc.subject | Boron | |
dc.subject | Boron-containing drugs | |
dc.subject | Boronic acids | |
dc.subject | Cross-coupling reactions | |
dc.subject | Drug discovery | |
dc.subject | Medicinal chemistry | |
dc.title | Boron in medicinal and organic chemistry | en |
dc.type | Resenha | pt |
dspace.entity.type | Publication | |
relation.isDepartmentOfPublication | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
relation.isDepartmentOfPublication.latestForDiscovery | e214da1b-9929-4ae9-b8fd-655e9bfeda4b | |
unesp.department | Fármacos e Medicamentos - FCF | pt |